Enabling Chemistry Technologies – Accelerators of Drug DiscoveryFriday, 7 June 2013 at 14:00 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com At AbbVie, a centralized, highly automated, state-of-the-art, parallel synthesis facility that enables the discovery of highly optimized biological tools and drug candidates is in place. The group specializes in the preparation of libraries of analogs designed to rapidly generate structure activity relationships (SAR) and accelerate lead development and optimization. |